{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:45:44Z","timestamp":1761237944254},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T00:00:00Z","timestamp":1350864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T00:00:00Z","timestamp":1350864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/bmt.2012.188","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T10:46:31Z","timestamp":1350902791000},"page":"491-501","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience"],"prefix":"10.1038","volume":"48","author":[{"given":"R","family":"Beier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"H\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Eyrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P-G","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Holter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K D","family":"Stachel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ehlert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Greil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"N\u00fcrnberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"W\u00f6\u00dfmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Suttorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Gruhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K-W","family":"Sykora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,22]]},"reference":[{"key":"BFbmt2012188_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1182\/blood-2002-11-3615","volume":"103","author":"J Casper","year":"2004","unstructured":"Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U et al. Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood 2004; 103: 725\u2013731.","journal-title":"Blood"},{"key":"BFbmt2012188_CR2","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1517\/13543784.2010.517744","volume":"19","author":"FK Glowka","year":"2010","unstructured":"Glowka FK, Romanski M, Wachowiak J . High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation. Expert. Opin Investig Drugs 2010; 19: 1275\u20131295.","journal-title":"Opin Investig Drugs"},{"key":"BFbmt2012188_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/sj.bmt.1705553","volume":"39","author":"M Sauer","year":"2007","unstructured":"Sauer M, Zeidler C, Meissner B, Rehe K, Hanke A, Welte K et al. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome. Bone Marrow Transplant 2007; 39: 143\u2013147.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012188_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2141.2008.07064.x","volume":"142","author":"B Greystoke","year":"2008","unstructured":"Greystoke B, Bonanomi S, Carr TF, Gharib M, Khalid T, Coussons M et al. Treosulfan-containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non-malignant disease and significant co-morbidities. Br J Haematol 2008; 142: 257\u2013262.","journal-title":"Br J Haematol"},{"key":"BFbmt2012188_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1365-2141.2008.07399.x","volume":"143","author":"R Cutting","year":"2008","unstructured":"Cutting R, Mirelman A, Vora A . Treosulphan as an alternative to busulphan for myeloablative conditioning in paediatric allogeneic transplantation. Br J Haematol 2008; 143: 748\u2013751.","journal-title":"Br J Haematol"},{"key":"BFbmt2012188_CR6","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1182\/blood-2010-10-312082","volume":"117","author":"MA Slatter","year":"2011","unstructured":"Slatter MA, Rao K, Amrolia P, Flood T, Abinun M, Hambleton S et al. Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. Blood 2011; 117: 4367\u20134375.","journal-title":"Blood"},{"key":"BFbmt2012188_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/bmt.2010.343","volume":"46","author":"J Wachowiak","year":"2011","unstructured":"Wachowiak J, Sykora KW, Cornish J, Chybicka A, Kowalczyk JR, Gorczynska E et al. Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party. Bone Marrow Transplant 2011; 46: 1510\u20131518.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012188_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbmt.2007.12.487","volume":"14","author":"S Matthes-Martin","year":"2008","unstructured":"Matthes-Martin S, Potschger U, Bergmann K, Frommlet F, Brannath W, Bauer P et al. Risk-adjusted outcome measurement in pediatric allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2008; 14: 335\u2013343.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012188_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1053\/j.gastro.2012.04.045","volume":"143","author":"D Kotlarz","year":"2012","unstructured":"Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 2012; 143: 347\u2013355.","journal-title":"Gastroenterology"},{"key":"BFbmt2012188_CR10","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1038\/bmt.2008.68","volume":"41","author":"J Wachowiak","year":"2008","unstructured":"Wachowiak J, Grund G, Sykora KW, Wynn RF, Kowalczyk JR, Drabko K et al. Treosulfan-based conditioning regimen for allogeneic transplantation in children congenital non-malignant disorders\u2014retrospective study. Bone Marrow Transplant 2008; 41: S80\u2013S343.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012188_CR11","first-page":"S1","volume":"45","author":"R Beier","year":"2010","unstructured":"Beier R, Schulz AS, Hoenig M, Schlegel G, Holter W, Stachel D et al. Treosulfan-based conditioning in children: retrospective analysis of the German and Austrian experience. Bone Marrow Transplant 2010; 45: S1\u2013S11.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012188_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/bmt.2012.36","volume":"47","author":"U Poetschger","year":"2012","unstructured":"Poetschger U, Sykora KW, Zecca M, Veys P, Lankaster A, Cant A et al. Meta-analysis on treosulfan for conditioning in children and adolescents before haematopoietic stem cell transplantation. Bone Marrow Transplant 2012; 47: S1\u2013S87.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012188_CR13","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012188_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","volume":"11","author":"AH Filipovich","year":"2005","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u2013956.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012188_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004; 33: 189\u2013195.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012188_CR16","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2141.2008.07385.x","volume":"143","author":"ME Bernardo","year":"2008","unstructured":"Bernardo ME, Zecca M, Piras E, Vacca A, Giorgiani G, Cugno C et al. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. Br J Haematol 2008; 143: 548\u2013551.","journal-title":"Br J Haematol"},{"key":"BFbmt2012188_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bbmt.2010.05.007","volume":"17","author":"ER Nemecek","year":"2011","unstructured":"Nemecek ER, Guthrie KA, Sorror ML, Wood BL, Doney KC, Hilger RA et al. Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies. Biol Blood Marrow Transplant 2011; 17: 341\u2013350.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2012188_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2141.2008.07179.x","volume":"142","author":"J Holowiecki","year":"2008","unstructured":"Holowiecki J, Giebel S, Wojnar J, Krawczyk-Kulis M, Markiewicz M, Holowiecka-Goral A et al. Treosulfan and fludarabine low-toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia. Br J Haematol 2008; 142: 284\u2013292.","journal-title":"Br J Haematol"},{"key":"BFbmt2012188_CR19","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/bmt.2010.153","volume":"46","author":"I Hilgendorf","year":"2011","unstructured":"Hilgendorf I, Wolff D, Gromke T, Trenschel R, Elmaagacli AH, Pichlmeier U et al. Retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning in patients with myelodysplastic syndrome. Bone Marrow Transplant 2011; 46: 502\u2013509.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012188_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.bmt.1704626","volume":"34","author":"M Koenigsmann","year":"2004","unstructured":"Koenigsmann M, Mohren M, Jentsch-Ullrich K, Franke A, Becker E, Heim M et al. High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation. Bone Marrow Transplant 2004; 34: 477\u2013483.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2012188_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00277-011-1253-9","volume":"91","author":"JM Chemnitz","year":"2012","unstructured":"Chemnitz JM, von Lilienfeld-Toal M, Holtick U, Theurich S, Shimabukuro-Vornhagen A, Krause A et al. Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukaemia. Ann Hematol 2012; 91: 47\u201355.","journal-title":"Ann Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2012188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012188","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2012188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T15:23:56Z","timestamp":1714490636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2012188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,22]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFbmt2012188"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2012.188","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,22]]},"assertion":[{"value":"22 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The following authors received financial support from Medac AG, Germany: Rita Beier, Ingo M\u00fcller and Karl-Walter Sykora research support. Karoline Ehlert, Ingo M\u00fcller and Karl-W Sykora travel grants. Meinolf Suttorp an educational grant. The other authors have no conflicts of interests in relation to this work to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}